Effect of Hyperbilirubinemia at the Beginning of Treatment on Myelosuppression in GnP Therapy for Pancreatic Cancer (Report 2)

○Saki Touda

[31P-am409S] Effect of Hyperbilirubinemia at the Beginning of Treatment on Myelosuppression in GnP Therapy for Pancreatic Cancer (Report 2)

○Saki Touda¹, Shigekazu Hirai², Tomohiro Ariyama^1,3, Masaki Takigawa¹, Masako Kinoshita¹, Toru Masaka¹, Masayuki Masuda¹ (1. Toho Univ., 2. Pharmaceutical Unit, Sakura Medical Center, Toho University, 3. Department of Pharmacy, Japanese Red Cross Medical Center)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[31P-am] Clinical Pharmacy

[31P-am409S] Effect of Hyperbilirubinemia at the Beginning of Treatment on Myelosuppression in GnP Therapy for Pancreatic Cancer (Report 2)

Password